AQR CAPITAL MANAGEMENT LLC

Position in PRAX — Praxis Precision Medicines, Inc.

CIK 1167557 Greenwich, CT

Position in PRAX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$19,567,133

+$668,761 QoQ

Shares Held

58,446

-0.4% QoQ

Ownership

0.209%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#64

of 308 holders

Holding Since

Jun 2022

11 quarters on record

Voting authority Sole 88% Shared 0% None 12%

Healthcare · as of Jun 30, 2026

AQR CAPITAL MANAGEMENT LLC holds $5,647,082,398 across 216 Biotechnology names. PRAX ranks #28 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	1,126,080	$702,155,918
2	INCY	Incyte Corp	5,320,901	$603,177,333
3	EXEL	Exelixis, Inc.	11,023,943	$599,812,735
4	JAZZ	Jazz Pharmaceuticals plc	1,522,568	$366,893,205
5	BMRN	Biomarin Pharmaceutical Inc	5,699,541	$326,127,732
6	VRTX	Vertex Pharmaceuticals Inc / Ma	616,170	$306,070,117
7	RVMD	Revolution Medicines, Inc.	1,295,450	$242,611,869
8	RPRX	Royalty Pharma plc	4,305,412	$241,404,446

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$19,567,133	58,446	-0.4%	Shares	Other	2026-08-14
2026-03-31	$18,898,372	58,656	+103.5%	Shares	Other	2026-05-15
2025-12-31	$8,496,762	28,828	+31.6%	Shares	Other	2026-02-17
2025-09-30	$1,160,912	21,904	+50.2%	Shares	Defined	2025-11-14
2025-06-30	$613,087	14,580	+117.5%	Shares	Other	2025-08-14
2024-12-31	$515,937	6,704	-73.5%	Shares	Defined	2025-02-14
2024-09-30	$1,453,919	25,268	-66.1%	Shares	Other	2024-11-14
2023-03-31	$60,346	74,594	-53.5%	Shares	Defined	2023-05-15
2022-12-31	$382,059	160,529	-36.2%	Shares	Defined	2023-02-14
2022-09-30	$571,477	251,752	+1347.2%	Shares	Defined	2022-11-14
2022-06-30	$42,620	17,396	—	Shares	Defined	2022-08-15
No filing history on record for this holder in this stock.